These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23803217)

  • 1. [Expression of Nusap1 in the surgical margins of hepatocellular carcinoma and its association with early recurrence].
    Zhang M; Yang D; Liu X; Liu Y; Liang J; He H; Zhong K; Lin L; Tao G; Zhang C; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):937-8, inside back cover. PubMed ID: 23803217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUSAP1, a novel stemness-related protein, promotes early recurrence of hepatocellular carcinoma.
    Li J; Tang M; Wu J; Qu H; Tu M; Pan Z; Gao C; Yang Y; Qu C; Huang W; Hong J
    Cancer Sci; 2022 Dec; 113(12):4165-4180. PubMed ID: 36106345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and clinical significance of Nusap1 in hepatical carcinoma].
    Zhang M; Yang D; Liu X; Liu Y; Liang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 38(9):876-81. PubMed ID: 24071699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma].
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1626-30. PubMed ID: 17359695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment.
    Inayoshi J; Ichida T; Sugitani S; Tsuboi Y; Genda T; Honma N; Asakura H
    J Gastroenterol Hepatol; 2003 Jun; 18(6):673-7. PubMed ID: 12753149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis.
    Roy S; Hooiveld GJ; Seehawer M; Caruso S; Heinzmann F; Schneider AT; Frank AK; Cardenas DV; Sonntag R; Luedde M; Trautwein C; Stein I; Pikarsky E; Loosen S; Tacke F; Ringelhan M; Avsaroglu SK; Goga A; Buendia MA; Vucur M; Heikenwalder M; Zucman-Rossi J; Zender L; Roderburg C; Luedde T
    Gastroenterology; 2018 Dec; 155(6):1951-1966.e26. PubMed ID: 30165047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
    Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription Factor E2F8 Promotes Cisplatin Resistance in Hepatocellular Carcinoma by Regulating DNA Damage via NUSAP1.
    Kong J; Xu S; Zhang P; Wang Y
    Int J Toxicol; 2023; 42(5):420-429. PubMed ID: 37331996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
    Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
    Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy.
    Chen HL; OuYang HY; Le Y; Jiang P; Tang H; Yu ZS; He MK; Tang YQ; Shi M
    Cancer Med; 2018 Nov; 7(11):5339-5350. PubMed ID: 30306706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma].
    Zhong C; Guo RP; Shi M; Wei W; Yu WS; Li JQ
    Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Tsuchiya K; Komuta M; Yasui Y; Tamaki N; Hosokawa T; Ueda K; Kuzuya T; Itakura J; Nakanishi H; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Sakamoto M; Izumi N
    Oncology; 2011; 80(3-4):278-88. PubMed ID: 21734420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma.
    Armengol C; Boix L; Bachs O; Solé M; Fuster J; Sala M; Llovet JM; Rodés J; Bruix J
    J Hepatol; 2003 May; 38(5):591-7. PubMed ID: 12713869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection.
    Wang Y; Tan PY; Handoko YA; Sekar K; Shi M; Xie C; Jiang XD; Dong QZ; Goh BKP; Ooi LL; Gao Z; Hui KM
    Int J Cancer; 2019 Aug; 145(3):662-670. PubMed ID: 30653265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma.
    Liu YB; Gao SL; Chen XP; Peng SY; Fang HQ; Wu YL; Peng CH; Tang Z; Xu B; Wang JW; Deng GL; Li HJ; Feng XD; Qian HR
    World J Gastroenterol; 2005 Mar; 11(9):1378-81. PubMed ID: 15761980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma.
    Matsumoto E; Nakatsukasa H; Nouso K; Kobayashi Y; Nakamura S; Suzuki M; Takuma Y; Tanaka H; Fujikawa T; Shiratori Y
    Liver Int; 2004 Aug; 24(4):379-83. PubMed ID: 15287862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
    J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.